Published in Neurology on October 23, 2001
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial. J Headache Pain (2007) 0.89
Migraine: diagnosis and management. J Neurol Neurosurg Psychiatry (2002) 0.87
The pharmacological management of migraine, part 1: overview and abortive therapy. P T (2008) 0.84
Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial. Postgrad Med J (2004) 0.84
Rizatriptan in the treatment of migraine. Neuropsychiatr Dis Treat (2006) 0.81
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Int J Clin Pract (2007) 0.81
Concentration effects of sumatriptan on the properties of model membranes by molecular dynamics simulations. Eur Biophys J (2013) 0.80
Triptan partition in model membranes. J Mol Model (2014) 0.77
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2002) 0.75
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2002) 0.75
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci (1996) 6.12
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA (1992) 4.77
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia (2010) 4.24
Screening for dementia with the memory impairment screen. Neurology (1999) 3.92
Clinical and prognostic subforms of new daily-persistent headache. Neurology (2010) 3.60
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia (2010) 3.54
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology (2007) 3.43
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study. Brain (2008) 3.38
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology (1996) 3.15
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
Burden of migraine in the United States: disability and economic costs. Arch Intern Med (1999) 3.05
A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med (2000) 2.90
The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia (2003) 2.87
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
Cardiovascular risk factors and migraine: the GEM population-based study. Neurology (2005) 2.86
Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84
Prevalence of frequent headache in a population sample. Headache (2004) 2.82
Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet (1999) 2.81
Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain (2003) 2.79
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78
Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax (2000) 2.74
The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology (1999) 2.69
Brain stem activation in spontaneous human migraine attacks. Nat Med (1995) 2.67
Influence of central set on human postural responses. J Neurophysiol (1989) 2.66
Epidemiology of tension-type headache. JAMA (1998) 2.63
Memory impairment on free and cued selective reminding predicts dementia. Neurology (2000) 2.58
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry (2010) 2.57
Postural strategies associated with somatosensory and vestibular loss. Exp Brain Res (1990) 2.54
Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology (2006) 2.51
Migraine and cardiovascular disease: a population-based study. Neurology (2010) 2.51
Migraine in adolescents: association with socioeconomic status and family history. Neurology (2007) 2.46
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke (2001) 2.45
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology (2001) 2.43
Global prevalence of chronic migraine: a systematic review. Cephalalgia (2010) 2.43
Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain (2000) 2.41
The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35
Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia (2010) 2.35
A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology (2005) 2.34
Syncope in migraine: the population-based CAMERA study. Neurology (2006) 2.33
Low blood pressure and the risk of dementia in very old individuals. Neurology (2003) 2.30
Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol (1999) 2.30
Hemicrania continua: ten new cases and a review of the literature. Neurology (1994) 2.26
The impact of migraine on quality of life in the general population: the GEM study. Neurology (2000) 2.24
Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia (2006) 2.23
A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry (1988) 2.21
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia (2010) 2.18
A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain (1997) 2.16
Memory and mental status correlates of modified Braak staging. Neurobiol Aging (2000) 2.15
Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology (2003) 2.14
Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia (2008) 2.12
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology (2004) 1.92
Headache and major depression: is the association specific to migraine? Neurology (2000) 1.91
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology (1999) 1.89
Education delays accelerated decline on a memory test in persons who develop dementia. Neurology (2007) 1.87
Recovery from Wernicke's aphasia: a positron emission tomographic study. Ann Neurol (1995) 1.86
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia (2008) 1.83
Dissociation of the lateral and medial cerebellum in movement timing and movement execution. Exp Brain Res (1988) 1.82
Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia (1999) 1.82
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther (2000) 1.76
Cerebellar control of postural scaling and central set in stance. J Neurophysiol (1994) 1.75
Phase I clinical and pharmacokinetic study of taxol. Cancer Res (1987) 1.74
Cumulative lifetime migraine incidence in women and men. Cephalalgia (2008) 1.73
The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J Gerontol B Psychol Sci Soc Sci (1996) 1.73
Gray matter decrease in patients with chronic tension type headache. Neurology (2005) 1.71
Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol (1993) 1.70
Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology (1999) 1.70
Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology (2001) 1.68
Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology (2011) 1.67
Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology (2008) 1.66
Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology (2007) 1.64
Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet (2001) 1.63
Pediatric migraine and the International Headache Society (IHS) criteria. Neurology (1997) 1.63
Localization of a cerebellar timing process using PET. Neurology (1995) 1.62
Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology (2010) 1.61
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. Int J Clin Pract (2009) 1.61
[Pain treatment facilities in Germany. Ambulatory, day care and inpatient facilities for patients with chronic pain]. Schmerz (2004) 1.61
Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache (1994) 1.59
A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology (1998) 1.57
Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology (2011) 1.57
Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol (1984) 1.57
Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia (2010) 1.56
Prevalence of cluster headache in a population-based sample in Germany. Cephalalgia (2007) 1.56
Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. Brain (2000) 1.56
Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia (2010) 1.56
A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology (2006) 1.54